Toronto-based Real Matters, a network management services platform for the mortgage and insurance industries, announced its second quarter 2019 financials on May 2, coming in with net revenue of $20.1 million, Adjusted EBITDA of $2.8 million and Adjusted EPS of $0.01 per share. (All figures in US dollars unless noted otherwise.)
Tse was calling for a top line of $17.5 million, an Adjusted EBITDA loss of $0.7 million and an Adjusted EPS of negative $0.01 per share. The analyst notes that REAL’s strong numbers were in large part due to a solid performance from its Appraisals segments, while its Title and Closing (T&C) platform lagged.
Tse says that key takeaways from the Q2 were: improvements in net revenue margin from its Appraisals unit, which is now live with all six Tier 1 lenders; weakness in the mortgage market for its T&C unit due to weak refinance activities; and a lower interest rate environment that worked to the company’s benefit.
“Despite a solid quarter, the sensitivity of the business to the macro environment and the fact that T&C has still not hit its stride suggests caution given the stock’s turn year to date, that’s had it inching towards our former target price of C$6.00 That said, the stock is also pricing in stronger expectations and given the continued headwind in refinance activity and rate uncertainty, we think the risk-to-reward profile looks balanced,” says Tse.
The analyst rates the impact of REAL’s Q2 as a positive while judging that the stock is now reasonably priced. His updated forecast calls for 2019 net revenue of $88.2 million and EBITDA of $12.1 million and his C$6.50 target represents a projected return of nine per cent at the time of publication.
ATB Capital Markets analyst Tim Monachello raised his rating on Questor Technology (Questor Technology Stock Quote, Chart, News, Analysts, Financials… [Read More]
Ventum Capital Markets analyst Amr Ezzat maintained a “Buy” rating and C$47.00 target price for Tecsys (Tecsys Stock Quote, Chart,… [Read More]
Roth Capital Markets analyst Scott Searle maintained a “Buy” rating and US$17.50 target price for Gogo (Gogo Stock Quote, Chart,… [Read More]
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$12.00 target price on Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock… [Read More]
Paradigm Capital analyst Marvin Wolff maintained a “Buy” rating and $0.55 target price for CHAR Technologies (CHAR Technologies Stock Quote,… [Read More]
Beacon Securities analyst Donangelo Volpe maintained a “Buy” rating and $2.00 target price for Imaflex (Imaflex Stock Quote, Chart, News,… [Read More]